73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model
New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc
Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind
New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study
Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainMetastatic or leptomeningeal disease (LMD), the spreading of a brain cancer to the meninges, is a devastating cancer complicat

Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainMetastatic or leptomeningeal disease (LMD), the spreading of a brain cancer to the meninges, is a devastating cancer complicat
Study suggests lung cancer does not decrease in line with reduced smoking

Study suggests lung cancer does not decrease in line with reduced smoking

byUmea UniversityIncidence rates for lung cancer according to age, sex and time (cases/100,000 person-years). Notice the different scales on the vertical axes (incidence rates). Credit:Eur

Study suggests lung cancer does not decrease in line with reduced smoking

byUmea UniversityIncidence rates for lung cancer according to age, sex and time (cases/100,000 person-years). Notice the different scales on the vertical axes (incidence rates). Credit:Eur
Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC

Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC

by European Society for Medical OncologyCredit: © European Society for Medical OncologyFirst-line osimertinib significantly lengthens overall survival compared to older generation EGFR-TKIs in pa

Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC

by European Society for Medical OncologyCredit: © European Society for Medical OncologyFirst-line osimertinib significantly lengthens overall survival compared to older generation EGFR-TKIs in pa
Study confirms curable state between single and widespread cancers

Study confirms curable state between single and widespread cancers

by University of Chicago Medical CenterRalph Weichselbaum, M.D., the Daniel K. Ludwig Distinguished Service Professor, chair of radiation and cellular oncology at UChicago and director of the Lud

Study confirms curable state between single and widespread cancers

by University of Chicago Medical CenterRalph Weichselbaum, M.D., the Daniel K. Ludwig Distinguished Service Professor, chair of radiation and cellular oncology at UChicago and director of the Lud
Study finds link between Medicaid expansion and equity in cancer care

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to
Leveraging the power of iPS cell technology to study myeloid neoplasm

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea
Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina
Phase 1 study: New medicine extends terminally-ill cancer patients' lives

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague